<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03115242</url>
  </required_header>
  <id_info>
    <org_study_id>P14/06_CUSCAS</org_study_id>
    <secondary_id>2014-A01181-46</secondary_id>
    <nct_id>NCT03115242</nct_id>
  </id_info>
  <brief_title>Contrast Enhanced Ultrasound of Carotid Plaque in Acute Ischemic Stroke</brief_title>
  <acronym>CUSCAS</acronym>
  <official_title>Contrast Enhanced Ultrasound of Carotid Plaque in Acute Ischemic Stroke</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Versailles Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Jennifer YEUNG (neurologist)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Aurélien MAURIZOT (angiologist)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Simon CHABAY (angiologist)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Daniela STANCIU (neurologist)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Versailles Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a biomedical, single-center, and prospective study of a consecutive patients cohort
      in acute ischemic stroke with carotid plaque.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The main objective of this study is to evaluate the prevalence of the contrast taking carotid
      plaques in these acute ischemic strokes.

      The secondary objectives are:

        -  to determine the clinical, sonographic, CT scanner and MRI characteristics of patients
           in constituted acute cerebral ischemia with carotid atherosclerotic plaque taking
           contrast to the doppler ultrasound.

        -  to explore of the plaque contrast enhancement at 6 months (new injection).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 2015</start_date>
  <completion_date type="Actual">August 2017</completion_date>
  <primary_completion_date type="Actual">August 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Contrast enhancement of carotid plaque prevalence in ultrasound doppler</measure>
    <time_frame>Day 1</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient's demographics data</measure>
    <time_frame>Day 1</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient's sonographic and MRI characteristics.</measure>
    <time_frame>Day1</time_frame>
    <description>confirmation of the recent character of stroke on the DWI, search for stroke sequelae and white matter disease on the FLAIR, search of the thrombus on the T2*, search occluded artery on the 3DTOF</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>describe the aspect of the carotid plaque on CT angiography.</measure>
    <time_frame>between 1 to 5 days</time_frame>
    <description>NASCET stenosis and the aspect (smooth, irregular, ulcerated)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Persistence , decrease or loss of contrast enhancement in ultrasound doppler.</measure>
    <time_frame>Month 6</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cerebral infarction recurrence</measure>
    <time_frame>Month 6</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">35</enrollment>
  <condition>Cerebral Infarction</condition>
  <arm_group>
    <arm_group_label>Acute ischemic carotid stroke</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients hospitalized in the neurovascular intensive care unit for an acute ischemic stroke with a carotid plaque responding to inclusion criteria.
These patients receive a contrast injection Sonovue® will be performed during the neck vessels doppler ultrasound.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Contrast injection Sonovue®</intervention_name>
    <description>In addition to standardized assessment routine care, a contrast injection will be performed during the neck vessels doppler ultrasound.</description>
    <arm_group_label>Acute ischemic carotid stroke</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients aged at least 18 years hospitalized with ischemic stroke signs in the
             carotid territory, objectified on brain MRI with positive DWI.

          -  Carotid plaque &gt; 2.5 mm thickness in the ipsilateral carotid territory to the AIC, low
             echogenicity (Type 1, 2, 3, and 4a of the classification Geroulakos) measured by the
             assessment &quot;GSM&quot; (median gray level).

          -  Free and informed consent patient or his representative for contrast injection
             microbubble.

          -  Affiliated to health insurance.

        Exclusion Criteria:

          -  Severe cerebral infarction with NIHSS&gt; 25

          -  No-indications to the contrast medium injection

          -  Recent myocardial infarction, unstable angina.

          -  Heart failure stage III / IV New York Heart Association.

          -  Cardiac shunt left-right, respiratory distress.

          -  Allergy to albumin or contrast agents.

          -  Carotid plaques and hyperechoic calcified (however these plaques will be counted to
             determine their prevalence in acute AIC).

          -  Carotid dissection
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jennifer YEUNG, Neurologist</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre hospitalier de versailles</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jean-Michel BAUD, Angiologist</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre hospitalier de versailles</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Aurélien MAURIZOT, Angiologist</last_name>
    <affiliation>Centre hospitalier de versailles</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Simon CHABAY, Angiologist</last_name>
    <affiliation>Centre hospitalier de versailles</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Daniela STANCIU, Neurologist</last_name>
    <affiliation>Centre hospitalier de versailles</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centre Hospitalier de Versailles</name>
      <address>
        <city>Le Chesnay</city>
        <zip>78150</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 5, 2016</study_first_submitted>
  <study_first_submitted_qc>April 10, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 14, 2017</study_first_posted>
  <last_update_submitted>March 14, 2018</last_update_submitted>
  <last_update_submitted_qc>March 14, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 15, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Versailles Hospital</investigator_affiliation>
    <investigator_full_name>Dr Jean-Michel BAUD</investigator_full_name>
    <investigator_title>Investigator coordinator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Cerebral Infarction</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

